Clinical trial results reveal new treatment for Covid-19 patients
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A drug used to treat rheumatoid arthritis could cut the number of Covid deaths and speed up recovery
a new scientific trial has found.
The drug, tocilizumab, could save the lives of one in 25 coronavirus patients in hospital and reduce the need for ventilators in intensive care.
Researchers say around half of the people admitted to hospital with coronavirus could benefit from the treatment.
Scientists from the nationwide Recovery trial said when tocilizumab was given alongside the steroid dexamethasone, it reduced the absolute risk of mortality by four percentage points.
The medicine was already being used by the NHS to treat some coronavirus patients after early results last month showed it reduced the risk of death as well as time spent in hospital by up to 10 days.
DISCLAIMER All news articles are shared for educational purposes only. The news content is hosted on the external news website. News articles titles are derived from the original news title, news content, dialogue, speech or general content theme. The news title may be edited and optimized for SEO, keyword density, information and internal website search purposes. You are advised to view the original news article for a better understanding. If you spot any mistakes, errors or omissions kindly contact us.